NCT06325748 2026-02-12SENTI-202: Off-the-shelf Logic Gated CAR NK Cell Therapy in Adults With CD33 and/or FLT3 Blood Cancers Including AML/MDSSenti BiosciencesPhase 1 Active not recruiting21 enrolled
NCT03246906 2025-06-04Comparison of Triple GVHD Prophylaxis Regimens for Nonmyeloablative or Reduced Intensity Conditioning Unrelated Mobilized Blood Cell TransplantationFred Hutchinson Cancer CenterPhase 2 Terminated150 enrolled
NCT00014235 2020-01-21Fludarabine Phosphate and Total-Body Radiation Followed by Donor Peripheral Blood Stem Cell Transplant and Immunosuppression in Treating Patients With Hematologic MalignanciesFred Hutchinson Cancer CenterPhase NA Completed160 enrolled